Mass spectrometry imaging in pulmonary disorders
-
Published:2024-07
Issue:
Volume:561
Page:119835
-
ISSN:0009-8981
-
Container-title:Clinica Chimica Acta
-
language:en
-
Short-container-title:Clinica Chimica Acta
Author:
Guan Chunliu,Kong Lu
Reference123 articles.
1. N. Wathoni, L.E. Puluhulawa, I.M. Joni, M. Muchtaridi, A.F.A. Mohammed, K.M. Elamin, T. Milanda, D. Gozali, Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer, Drug Deliv 29 (n.d.) 2959–2970. doi: 10.1080/10717544.2022.2120566.
2. Dissecting lung development and fibrosis at single-cell resolution;Farber;Genome Med.,2019
3. A census of the lung: CellCards from LungMAP, Developmental Cell 57 (2022) 112-145.e2. doi: 10.1016/j.devcel.2021.11.007.
4. Tackling the global burden of lung disease through prevention and early diagnosis;Agusti;Lancet Respir. Med.,2022
5. Liquid chromatography–tandem mass spectrometry for clinical diagnostics;Thomas;Nat. Rev.. Methods Primers,2022